Clinical Research Directory

Inclusion Criteria: 1. Patients currently implanted with the CT LUCIA 621P IOL into the capsular bag in at least one eye and who participated in previous study "CT LUCIA 621P-BER-401-21"; 2. A minimum follow-up period of 24 months after the IOL implantation of the study eye (selected as the study eye in the previous study); 3. Patients willing and capable of providing informed consent; 4. Patients willing and capable of complying with visits and procedures as defined by this protocol. Exclusion Criteria: 1. Complications during cataract surgery with clinically significant impact; 2. Postoperative clinically significant corneal or retinal pathology as well as postoperative acute or chronic inflammatory ocular conditions (e.g. uveitis, iritis etc.); 3. Presence of clinically significant PCO with potential to limit the glistening evaluation; 4. IOL dislocation (the complete IOL is not stable fixated in the capsular bag); 5. Patients unable to meet the limitations of the protocol or likely of non-cooperation during the clinical investigation; 6. Patients whose freedom is impaired by administrative or legal order.